跳至主要内容
临床试验/NCT00853515
NCT00853515终止不适用

A Randomized-controlled Trial of a Targeted Approach to Fluid Resuscitation in Acute Pancreatitis

Brigham and Women's Hospital1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2009年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
40
试验地点
1
主要终点
Prevalence (point prevalence) of the systemic inflammatory response syndrome (SIRS) at 24 hours

研究概览

简要总结

Vigorous fluid resuscitation is currently believed to play a key role in reducing complications associated with acute pancreatitis. However, aggressive fluid replacement can be associated with complications such as pulmonary fluid sequestration. The purpose of this study is to evaluate alternative approaches to early fluid resuscitation for patients with acute pancreatitis.

详细描述

Primary Aim: Evaluate the impact of a goal-directed fluid resuscitation protocol compared to standard fluid resuscitation on systemic inflammation in patients with acute pancreatitis.

Secondary Aim: Evaluate the impact of resuscitation with Lactated Ringer's compared to normal saline on systemic inflammation in acute pancreatitis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •acute pancreatitis diagnosed by at least 2 criteria
  • •adult patients at least 18 years of age

排除标准

  • •history of severe cardiovascular, respiratory, renal, hepatic or hematologic/immunologic disease
  • •concurrent metabolic or physiologic derangement requiring specific fluid management
  • •pregnancy
  • •patients transferred from acute care hospital

研究组 & 干预措施

1

Experimental

Goal-directed fluid resuscitation with lactated Ringer's solution

干预措施: Goal-directed fluid resuscitation (Other)

2

Experimental

Goal-directed fluid resuscitation with normal saline

干预措施: Goal-directed fluid resuscitation (Other)

3

No Intervention

Standard fluid resuscitation with lactated Ringer's solution

4

No Intervention

Standard fluid resuscitation with normal saline

结局指标

主要结局

Prevalence (point prevalence) of the systemic inflammatory response syndrome (SIRS) at 24 hours

时间窗: first 24 hours of hospitalization

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Bechien Wu, MD, MPH

Bechien Wu, M.D., M.P.H.

Brigham and Women's Hospital

研究点 (1)

Loading locations...

相似试验